Structure of 178747-50-7
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 178747-50-7 |
Formula : | C7H3ClFNO |
M.W : | 171.56 |
SMILES Code : | FC1=CC=C(ON=C2Cl)C2=C1 |
MDL No. : | MFCD11846403 |
InChI Key : | NXXMYNTVLHIRDD-UHFFFAOYSA-N |
Pubchem ID : | 15453973 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Num. heavy atoms | 11 |
Num. arom. heavy atoms | 9 |
Fraction Csp3 | 0.0 |
Num. rotatable bonds | 0 |
Num. H-bond acceptors | 3.0 |
Num. H-bond donors | 0.0 |
Molar Refractivity | 38.98 |
TPSA ? Topological Polar Surface Area: Calculated from |
26.03 Ų |
Log Po/w (iLOGP)? iLOGP: in-house physics-based method implemented from |
2.11 |
Log Po/w (XLOGP3)? XLOGP3: Atomistic and knowledge-based method calculated by |
2.77 |
Log Po/w (WLOGP)? WLOGP: Atomistic method implemented from |
3.04 |
Log Po/w (MLOGP)? MLOGP: Topological method implemented from |
2.42 |
Log Po/w (SILICOS-IT)? SILICOS-IT: Hybrid fragmental/topological method calculated by |
2.96 |
Consensus Log Po/w? Consensus Log Po/w: Average of all five predictions |
2.66 |
Log S (ESOL):? ESOL: Topological method implemented from |
-3.25 |
Solubility | 0.0955 mg/ml ; 0.000557 mol/l |
Class? Solubility class: Log S scale |
Soluble |
Log S (Ali)? Ali: Topological method implemented from |
-2.97 |
Solubility | 0.183 mg/ml ; 0.00107 mol/l |
Class? Solubility class: Log S scale |
Soluble |
Log S (SILICOS-IT)? SILICOS-IT: Fragmental method calculated by |
-3.8 |
Solubility | 0.0269 mg/ml ; 0.000157 mol/l |
Class? Solubility class: Log S scale |
Soluble |
GI absorption? Gatrointestinal absorption: according to the white of the BOILED-Egg |
High |
BBB permeant? BBB permeation: according to the yolk of the BOILED-Egg |
Yes |
P-gp substrate? P-glycoprotein substrate: SVM model built on 1033 molecules (training set) |
No |
CYP1A2 inhibitor? Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set) |
Yes |
CYP2C19 inhibitor? Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set) |
No |
CYP2C9 inhibitor? Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set) |
No |
CYP2D6 inhibitor? Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set) |
No |
CYP3A4 inhibitor? Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set) |
No |
Log Kp (skin permeation)? Skin permeation: QSPR model implemented from |
-5.38 cm/s |
Lipinski? Lipinski (Pfizer) filter: implemented from |
0.0 |
Ghose? Ghose filter: implemented from |
None |
Veber? Veber (GSK) filter: implemented from |
0.0 |
Egan? Egan (Pharmacia) filter: implemented from |
0.0 |
Muegge? Muegge (Bayer) filter: implemented from |
1.0 |
Bioavailability Score? Abbott Bioavailability Score: Probability of F > 10% in rat |
0.55 |
PAINS? Pan Assay Interference Structures: implemented from |
0.0 alert |
Brenk? Structural Alert: implemented from |
0.0 alert: heavy_metal |
Leadlikeness? Leadlikeness: implemented from |
No; 1 violation:MW<1.0 |
Synthetic accessibility? Synthetic accessibility score: from 1 (very easy) to 10 (very difficult) |
2.48 |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
43% | With pyridine; 1,8-diazabicyclo[5.4.0]undec-7-ene; at 110.0℃; for 18.0h; | (Octahydro-quinazolin-3-yl)-methanol (5.42 g, 26.2 mmol), 1, 8-diazobicyclo [5.4. 0] - undec-7-ene (12.9 ML, 85 mmol), and <strong>[178747-50-7]3-chloro-5-fluoro-benzo[d]isoxazole</strong> (5.54 g, 32.3 MMOL) were dissolved in pyridine (16 ML), and then heated (110C) with stirring for 18 hours. 10% aqueous sodium bicarbonate and methylene chloride (250 ml of each) were added, and the mixture was vigorously stirred. The aqueous phase was then re-extracted with three 100 ml portions of fresh methylene chloride. The combined organic extracts were dried (anhydrous sodium sulfate) and concentrated in vacuo to an amorphous solid (4.88 g). Flash chromatography of the entire sample (silica gel, 47-61 micron mesh; elution with methanol/methylene chloride = 6.94 in volume) afforded the title compound (3.46 g, 43% yield) as an amorphous solid. MS m/z 306 (M+1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77% | (a) 3-Chloro-5-fluoro-1,2-benzisoxazole. To a solution of 5-fluoro-3-hydroxyisoxazole (1.0 g) in pyridine (0.53 ml) was added phosphorus oxychloride (0.89 ml) and the mixture was refluxed for 8 hours. The reaction mixture was poured into ice water, extracted with ethyl acetate and the combined extracts were washed with saturated salt water and dried over anhydrous magnesium sulphate. After filtration, the solvent was evaporated under reduced pressure and the residue was purified by silica gel column chromatography, to give the title compound (0.85 g, 77%) as a colorless oil. | |
52% | Step 4 3-Chloro-5-fluoro-benzo[d]isoxazole To a mixture of the Step 3 title compound (1.68 g, 11 mmol) and phosphous oxychloride (2.46 ml, 26 mmol), pyridine (979 mul) was added. The resulting reaction mixture was heated at 100 C. for 18 hours. Cooled to ambient temperature, the mixture was cautiously added to water (15 ml). After 5 minutes of stirring, a solid precipitate formed, which was filtered. The filter cake was washed with water (5 ml and dried in vacuo, affording the title compound as a tan amorphous solid (973 mg, 52% yield). 1H NMR (400 MHz, CD3OD) delta7.50 (m, 2H), 7.72 (m, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; In pyridine; diethyl ether; dichloromethane; ethyl acetate; | The Step 4 title compound (dihydrochloride salt; 125 mg, 0.31 mmol), 1,8-diazabicyclo[5.4.0]-undec-7-ene (153 mul, 1.0 mmol), and <strong>[178747-50-7]3-chloro-5-fluoro-benzo[d]isoxazole</strong> (66 mg, 0.39 mmol) were dissolved in pyridine (150 mul). The reaction was heated at 90 C. for 18 hours. 10% aqueous sodium bicarbonate and methylene chloride (15 ml of each) were added to the well-stirred mixture. The aqueous phase was then re-extracted with three 15 ml portions of fresh methylene chloride. The combined organic extracts were dried (anhydrous sodium sulfate) and the solvent was removed in vacuo. Purification of the oily semi-solid residue (150 mg) by flash chromatography (silica gel, 47-61 micron mesh; elution with methanol/methylene chloride=7.5:92.5 in volume) afforded the tile compound (free base) as a colorless amorphous solid (57 mg. 36% yield). Dissolution of the entire sample in ethyl acetate/methylene chloride (1.0 ml of each), addition of a saturated diethyl ether solution of anhydrous hydrogen chloride (3 ml); and finally, solvent removal in vacuo afforded the title compound dihydrochloride as an amorphous solid. Free base data: 13C NMR (75 MHz, CDCl3) delta161.62, 160.91, 159.45, 158.45, 141.54, 129.55, 121.70, 118.44, 116.88, 115.28, 113.35, 111.73, 107.76, 71.26, 61.21, 60.55, 59.20, 54.68, 54.60, 54.12, 48.71, 36.88, 29.43, 27.37, 23.90 ppm; MS m/z 465 (M+1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With potassium carbonate; In N-methyl-acetamide; | (b) 3-(2-(N-t-Butoxycarbonylamino)ethylthio)-5-fluoro-1,2-benzisoxazole. To a solution of <strong>[178747-50-7]3-chloro-5-fluoro-1,2-benzisoxazole</strong> (0.83 g) in dimethylformamide (8 ml) was added 2-t-butoxycarbonylaminoethanethiol (0.86 g) and potassium carbonate (0.67 g) with stirring under nitrogen atmosphere, and the mixture was then stirred at 80 C. for 3 hours. The reaction mixture was poured into ice water, extracted with ethyl acetate and the combined extracts were washed with brine and dried over anhydrous magnesium sulphate. After filtration, the solvent was evaporated under reduced pressure and the residue was purified by silica gel column chromatography, to give the title compound (1.21 g, 80%) as a colorless powder. NMR spectrum(CDCl3)deltappm: 1.44(9H,s), 3.41(2H,t,J=6.2 Hz), 3.58(2H,td,J=6.2 Hz,J=6.2 Hz), 4.98(1H,brs), 7.21-7.51(3H,m). |
A197772 [374554-89-9]
3-Chloro-6-fluorobenzo[d]isoxazole
Similarity: 0.99
A112830 [1018297-63-6]
(3-(4-Fluorophenyl)-5-methylisoxazol-4-yl)methanol
Similarity: 0.64
A260130 [206055-89-2]
(3-(4-Fluorophenyl)isoxazol-5-yl)methanol
Similarity: 0.63
A107113 [177995-38-9]
6-Fluorobenzo[d]isoxazol-3-ylamine
Similarity: 0.62
A153776 [84163-13-3]
6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride
Similarity: 0.58
A197772 [374554-89-9]
3-Chloro-6-fluorobenzo[d]isoxazole
Similarity: 0.99
A146182 [401567-43-9]
5-Bromo-3-chlorobenzo[d]isoxazole
Similarity: 0.79
A130314 [1243389-57-2]
6-Bromo-3-chlorobenzo[d]isoxazole
Similarity: 0.78
A197772 [374554-89-9]
3-Chloro-6-fluorobenzo[d]isoxazole
Similarity: 0.99
A146182 [401567-43-9]
5-Bromo-3-chlorobenzo[d]isoxazole
Similarity: 0.79
A130314 [1243389-57-2]
6-Bromo-3-chlorobenzo[d]isoxazole
Similarity: 0.78